Abstract 1185: H3B-8800, a novel orally available SF3b modulator, shows preclinical efficacy across spliceosome mutant cancers
Silvia Buonamici,Akihide Yoshimi,Michael Thomas,Michael Seiler,Betty Chan,Benjamin Caleb,Fred Csibi, Rachel Darman,Peter Fekkes,Craig Karr, Gregg Keaney,Amy Kim,Virginia Klimek,Pavan Kumar,Kaiko Kunii,Stanley Chun-Wei Lee, Xiang Liu,Crystal MacKenzie,Carol Meeske,Yoshiharu Mizui, Eric Padron,Eunice Park,Ermira Pazolli,Sudeep Prajapati,Nathalie Rioux,Justin Taylor,John Wang,Markus Warmuth,Huilan Yao,Lihua Yu,Ping Zhu,Omar Abdel-Wahab,Peter Smith Experimental and Molecular Therapeutics（2017）
AI 理解论文
溯源树
样例
